AR079569A1 - Derivados de pirrolopiridinil-pirimidin-2-il-amina, procedimientos de preparacion y sus usos - Google Patents
Derivados de pirrolopiridinil-pirimidin-2-il-amina, procedimientos de preparacion y sus usosInfo
- Publication number
- AR079569A1 AR079569A1 ARP100104796A ARP100104796A AR079569A1 AR 079569 A1 AR079569 A1 AR 079569A1 AR P100104796 A ARP100104796 A AR P100104796A AR P100104796 A ARP100104796 A AR P100104796A AR 079569 A1 AR079569 A1 AR 079569A1
- Authority
- AR
- Argentina
- Prior art keywords
- het1
- substituted simply
- hal
- simply
- atoms
- Prior art date
Links
- 238000000034 method Methods 0.000 title 1
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000002098 pyridazinyl group Chemical group 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 230000004663 cell proliferation Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000002757 morpholinyl group Chemical group 0.000 abstract 1
- 125000004193 piperazinyl group Chemical group 0.000 abstract 1
- 125000003386 piperidinyl group Chemical group 0.000 abstract 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
- 125000003226 pyrazolyl group Chemical group 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 125000000714 pyrimidinyl group Chemical group 0.000 abstract 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 abstract 1
- 125000005301 thienylmethyl group Chemical group [H]C1=C([H])C([H])=C(S1)C([H])([H])* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- AIDS & HIV (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102009060174A DE102009060174A1 (de) | 2009-12-23 | 2009-12-23 | Pyrrolopyridinyl-pyrimidin-2-yl-amin-derivate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR079569A1 true AR079569A1 (es) | 2012-02-01 |
Family
ID=43531962
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP100104796A AR079569A1 (es) | 2009-12-23 | 2010-12-20 | Derivados de pirrolopiridinil-pirimidin-2-il-amina, procedimientos de preparacion y sus usos |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8575163B2 (enExample) |
| EP (1) | EP2516431B1 (enExample) |
| JP (1) | JP5847091B2 (enExample) |
| CN (1) | CN102666538B (enExample) |
| AR (1) | AR079569A1 (enExample) |
| AU (1) | AU2010335628B2 (enExample) |
| CA (1) | CA2785307C (enExample) |
| DE (1) | DE102009060174A1 (enExample) |
| ES (1) | ES2537412T3 (enExample) |
| WO (1) | WO2011076316A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2816088A1 (en) | 2010-10-28 | 2012-05-03 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitor compounds |
| DE102010050558A1 (de) * | 2010-11-05 | 2012-05-10 | Merck Patent Gmbh | 1H-Pyrrolo[2,3-b]pyridinderivate |
| DE102010053347A1 (de) * | 2010-12-03 | 2012-06-06 | Merck Patent Gmbh | 3-Hetaryl-substituierte Pyrrolo[2,3-b] pyridin-derivative als PDK1-Inhibitoren |
| JP6130383B2 (ja) * | 2011-09-30 | 2017-05-17 | エンドゥ ファーマシューティカルズ，インコーポレイティド | ピリジン誘導体 |
| CN107550905B (zh) * | 2017-09-11 | 2020-07-17 | 浙江永宁药业股份有限公司 | 多取代吡咯并吡啶类化合物的药物用途及其制备方法 |
| CN113423707A (zh) * | 2018-11-16 | 2021-09-21 | 加利福尼亚技术学院 | Erk抑制剂及其用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5747469A (en) | 1991-03-06 | 1998-05-05 | Board Of Regents, The University Of Texas System | Methods and compositions comprising DNA damaging agents and p53 |
| GB9904387D0 (en) | 1999-02-25 | 1999-04-21 | Pharmacia & Upjohn Spa | Antitumour synergistic composition |
| GB0308466D0 (en) | 2003-04-11 | 2003-05-21 | Novartis Ag | Organic compounds |
| ES2364340T3 (es) * | 2004-03-30 | 2011-08-31 | Vertex Pharmaceuticals Incorporated | Azaindoles útiles como inhibidores de jak y otras proteína quinasas. |
| DE102007028515A1 (de) * | 2007-06-21 | 2008-12-24 | Merck Patent Gmbh | 6-(Pyrrolopyridinyl)-pyrimidinyl-2-amin-derivate |
| DE102008031517A1 (de) | 2008-07-03 | 2010-01-07 | Merck Patent Gmbh | Pyrrolopyridinyl-pyrimidin-2-yl-amin-derivate |
-
2009
- 2009-12-23 DE DE102009060174A patent/DE102009060174A1/de not_active Withdrawn
-
2010
- 2010-11-12 CA CA2785307A patent/CA2785307C/en not_active Expired - Fee Related
- 2010-11-12 EP EP10778880.4A patent/EP2516431B1/de not_active Not-in-force
- 2010-11-12 JP JP2012545114A patent/JP5847091B2/ja not_active Expired - Fee Related
- 2010-11-12 US US13/518,726 patent/US8575163B2/en not_active Expired - Fee Related
- 2010-11-12 ES ES10778880.4T patent/ES2537412T3/es active Active
- 2010-11-12 CN CN201080058668.1A patent/CN102666538B/zh not_active Expired - Fee Related
- 2010-11-12 AU AU2010335628A patent/AU2010335628B2/en not_active Ceased
- 2010-11-12 WO PCT/EP2010/006911 patent/WO2011076316A1/de not_active Ceased
- 2010-12-20 AR ARP100104796A patent/AR079569A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US8575163B2 (en) | 2013-11-05 |
| ES2537412T3 (es) | 2015-06-08 |
| DE102009060174A1 (de) | 2011-06-30 |
| EP2516431B1 (de) | 2015-04-15 |
| CA2785307A1 (en) | 2011-06-30 |
| AU2010335628B2 (en) | 2016-03-03 |
| AU2010335628A1 (en) | 2012-08-09 |
| US20120270871A1 (en) | 2012-10-25 |
| EP2516431A1 (de) | 2012-10-31 |
| WO2011076316A1 (de) | 2011-06-30 |
| JP2013515685A (ja) | 2013-05-09 |
| CA2785307C (en) | 2017-10-31 |
| JP5847091B2 (ja) | 2016-01-20 |
| CN102666538A (zh) | 2012-09-12 |
| CN102666538B (zh) | 2015-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR122902A2 (es) | Compuestos terapéuticamente activos y sus métodos de preparación | |
| CR11738A (es) | Compuestos de pirimidinona pirrolo 3-metil-2-imino fenil sustituidos como inhibidores bace-1, composiciones y su uso | |
| BR112012029647A2 (pt) | novos derivados de pirimidinas | |
| NI201400023A (es) | Derivados de pirrolopirimidina y purina | |
| NZ629432A (en) | Heterocyclyl compounds as mek inhibitors | |
| PE20151601A1 (es) | Compuestos novedosos de pirimidina y piridina y su uso | |
| NI201800033A (es) | Derivados de 8-[6-[3-(amino)propoxi]-3piridil]-1-isopropil-imidazo[4, 5-c]quinolin -2-ona como moduladores selectivos de la cinasa de la ataxia telangiectasia mutada (atm) para el tratamiento del cáncer. | |
| EA201400338A1 (ru) | Производные аминопиримидина для применения в качестве модуляторов киназной активности | |
| PE20160540A1 (es) | Inhibidores de bromodominios | |
| NZ602726A (en) | Pyrazolyl quinoxaline kinase inhibitors | |
| DOP2012000153A (es) | Derivados de sulfonamida como agentes inductores de apoptosis con selectividad por bcl-2 para el tratamiento de cancer y enfermedades inmunes | |
| SG194675A1 (en) | Derivatives of n- [(1h-pyrazol-1-yl) aryl] - 1h - indole or 1h - indazole - 3 - carboxamide, their preparation and their use as p2y12 antagonists | |
| UY34426A (es) | Derivados de heteroarilcarboxamida, procesos de preparación, composiciones y sus usos en agricultura, veterinaria y control de plagas | |
| AR095347A1 (es) | Compuestos orgánicos | |
| AR053569A1 (es) | Derivados de pirazol | |
| CR20160523A (es) | Compuestos de imidazo[4,5-c]quinolin-2-ona y su uso para tratar cáncer | |
| UA116923C2 (uk) | (6S,9aS)-N-БЕНЗИЛ-6-[(4-ГІДРОКСИФЕНІЛ)МЕТИЛ]-4,7-ДІОКСО-8-({6-[3-(ПІПЕРАЗИН-1-ІЛ)АЗЕТИДИН-1-ІЛ]ПІРИДИН-2-ІЛ}МЕТИЛ)-2-(ПРОП-2-ЕН-1-ІЛ)-ОКТАГІДРО-1H-ПІРАЗИНО[2,1-c][1,2,4]ТРИАЗИН-1-КАРБОКСАМІДНА СПОЛУКА | |
| AR077975A1 (es) | Derivados de pirazol pirimidina y composiciones como inhibidores de cinasa de proteina | |
| BR112015023412A2 (pt) | 3-pirimidin-4-il-oxazolidin-2-onas como inibidores de idh mutante | |
| BR112014014909A2 (pt) | agonistas de tgr5 não sistêmicos | |
| MX2014002683A (es) | Derivados de benzonitrilo como inhibidores de cinasa. | |
| AR093512A1 (es) | Derivados heterociclicos como moduladores de la actividad de cinasas | |
| CO6491058A2 (es) | Derivados de oxazina y su uso como inhibidores de bace para el tratamiento de trastornos neurológicos | |
| HRP20090208T1 (hr) | Supstituirani derivati pirido[2,3-d]pirimidina korisni kao lijekovi za liječenje autoimunih bolesti | |
| CL2013003056A1 (es) | Compuestos derivados de (fenil o piridin)-etinil-(piridin o pirimidin) sustituido; composición farmacéutica que los comprende; proceso de preparación de esto; y su uso en el tratamiento de la esquizofrenia o enfermedades cognitivas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |